Ataxia telangiectasia: more variation at clinical and cellular levels

Keyphrases

• Ataxia Telangiectasia 100%
• Cellular Level 100%
• Clinical Levels 100%
• Allelic Heterogeneity 66%
• DNA Repair 33%
• Apoptosis 33%
• ATM Protein 33%
• DNA Damage 33%
• Cellular Response 33%
• Serine-threonine Kinase 33%
• Clinical Phenotype 33%
• Clinical Features 33%
• Missense 33%
• Neurological Deterioration 33%
• DNA Double-strand Breaks 33%
• Inherited Disorders 33%
• Biallelic mutations 33%
• Splicing mutation 33%
• Clinical Heterogeneity 33%
• Cell Cycle Checkpoint 33%
• MRE11 33%
• ATM Gene 33%
• Ataxia-telangiectasia-like Disorder 33%
• Locus Heterogeneity 33%
• RNF168 33%
• Immunological Defects 33%
• Transphosphorylation 33%

Biochemistry, Genetics and Molecular Biology

• DNA Damage Response 100%
• Allele 100%
• Casein Kinase 100%
• DNA Repair 100%
• Cell Cycle Checkpoint 100%
• Missense 100%
• Splice Site Mutation 100%
• Double-Strand DNA Break 100%
• Programmed Cell Death 100%